GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IN8bio Inc (STU:6JH0) » Definitions » Margin of Safety % (DCF Earnings Based)

IN8bio (STU:6JH0) Margin of Safety % (DCF Earnings Based) : N/A (As of Jun. 27, 2025)


View and export this data going back to 2023. Start your Free Trial

What is IN8bio Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

IN8bio's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

Competitive Comparison of IN8bio's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, IN8bio's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IN8bio's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IN8bio's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where IN8bio's Margin of Safety % (DCF Earnings Based) falls into.


;
;

IN8bio Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of IN8bio's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

IN8bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IN8bio Inc (STU:6JH0) » Definitions » Margin of Safety % (DCF Earnings Based)
Comparable Companies
NKGN ZEOX SYBX CLDI ICU PRTG LIPO UBX ABP MBRX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
INAB:USA 6JH:Germany
Address
350 5th Avenue, Suite 5330, New York, NY, USA, 10118
Website
https://www.in8bio.com
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

IN8bio Headlines

No Headlines